All
Daily Derm Times: April 29, 2025
Catch up on dermatology news, highlights, and insights from the past 24 hours.
Understanding the Role of OX40 in Next-Generation Eczema Therapies
Acting upstream of cytokines may hold the key to improving biologic efficacy and itch relief in AD.
How Does Psoriasis Influence Sun Tanning Addiction?
Younger patients with moderate to severe psoriasis exhibit risky sun exposure behaviors, raising concerns about tanning addiction and skin cancer risks.
Interview Intersection: Expert Interviews From April 2025
Dermatology Times is recapping our exclusive expert interviews from the month of April.
Newly Developed Questionnaire Evaluates Quality of Life for Patients with Hair and Scalp Conditions
The innovative 21-item Hair & Scalp CARE questionnaire is designed to evaluate the psychological impact of hair and scalp conditions on quality of life.
FDA Approves First Gene Therapy for RDEB
The FDA approved pz-cel, a groundbreaking gene therapy for recessive dystrophic epidermolysis bullosa, transforming treatment options for patients.
Subgroup Case Series Reveals JAKi Efficacy for Black Patients With AA
JAK inhibitors show promise in treating alopecia areata among Black patients, highlighting the need for inclusive clinical research and equitable access to therapies.
Daily Derm Times: April 28, 2025
Dermatology Times April 2025 Print Recap
Learn more about the in-depth topics covered in the April 2025 print issue of Dermatology Times.
Novel Serum Improves Facial Skin Quality in Patients Using GLP-1 Receptor Agonists
The groundbreaking GLPSGLT serum enhances skin quality for GLP-1 RA users, improving elasticity and reducing wrinkles in just 6 weeks.
Jonathan Silverberg, MD, PhD, MPH on Keeping Up With Rapid AD Developments
Discover cutting-edge insights on atopic dermatitis at RAD 2025, featuring expert discussions and the latest therapies to enhance your practice.
Positive Correlation Between Acne and BMI in Adolescent Patients in Sudan
A new study reveals a significant link between acne prevalence and high BMI in Sudanese adolescents, highlighting gender differences and the need for further research.
The Vicious Cycle of Itch, Stress, and Sleep Loss
Real-World Study Highlights Burden of Moderate to Severe Atopic Dermatitis in Children and Adolescents
A new study reveals ongoing burden of moderate to severe atopic dermatitis in youth, with flares, comorbidities, and quality of life impacts.
Top 5 Articles of the Week: April 20-25
Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.
Dermatology Times' Sunday Crossword: April 27, 2025
Test your knowledge of key words and terms associated with dermatology news from the previous week.
The Weekly Roundup: April 21-25
In case you missed it, this week we had news about the future of regenerative aesthetics, biologic therapies for bullous pemphigoid, phase 3 trial results for Qtorin 3.9% rapamycin gel, and more.
The Rx Recap: April 20-25
This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.
Daily Derm Times: April 25, 2025
Xerosis Management: Back to Basics with Emollients
Explore the effectiveness of basic emollients in treating xerosis cutis associated with atopic dermatitis, enhancing skin hydration and barrier function.
Can Colloidal Oat Emollients Be Used to Treat Pediatric Atopic Dermatitis?
Sophisticated colloidal oat emollients show promise in effectively managing pediatric atopic dermatitis, enhancing skin hydration and reducing flare-ups in infants.
Hyaluronic Acid Boosts Results in Rosacea Management
Discover innovative rosacea treatments combining injectable hyaluronic acid with traditional therapies to enhance skin health and boost patient confidence.
Deuruxolitinib is Most Effective Monotherapy for Alopecia, According to Meta-Analysis
A recent meta-analysis evaluates the efficacy and safety of various JAK inhibitors for alopecia areata, highlighting 12 mg twice daily deuruxolitinib as the most effective treatment.
FDA Places Clinical Hold on VYNE’s VYN202 Phase 1b Trial for Plaque Psoriasis
VYNE Therapeutics paused its VYN202 trial for psoriasis due to an FDA-issued clinical hold.
Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care
Discover how the RAD conference in Nashville enhances atopic dermatitis care, featuring expert insights and patient-focused strategies for clinicians.
Daily Derm Times: April 24, 2025
Stopping Adjuvant Immunotherapy Early May Not Worsen Outcomes in Resected Metastatic Melanoma
New research reveals that early discontinuation of adjuvant immunotherapy for melanoma does not lead to worse outcomes.
Novel Microneedle Radiofrequency Device is Safe for Horizontal Neck Wrinkles
A pilot study reveals a dual-length microneedle RF device effectively reduces neck wrinkles by 35%, enhancing skin hydration and elasticity with minimal downtime.
Upadacitinib Outpaces Dupilumab in Rapid AD Symptom Control
Discover how upadacitinib outperforms dupilumab in providing rapid itch relief for moderate-to-severe atopic dermatitis in a recent AAD study.
Managing Wound Risks in Patients on TKIs
Explore how tyrosine kinase inhibitors hinder wound healing, revealing critical insights for clinicians in dermatology and oncology.